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In Australia and the United Kingdom,consultation for acute respiratory infec-
tion (ARI) is very common.1,2
Approximately 3.9% of all consultations
for a new problem in Australia are for
acute bronchitis (3.5 per 100 consulta-
tions), with antibiotics being prescribed in
about 80% of cases.1,3 Acute bronchitis
can have considerable impact on patients’
lives.4 Antibiotics are thought to be over
prescribed for these conditions5 and a
recent systematic review of treatment for
acute bronchitis, concluded that the
benefit from antibiotic treatment was
modest.6 Although it is recognised that
patient factors influence the prescription
of antibiotics7,8 little is known about
general practitioners preferred rather than
actual behaviour with respect to the pre-
scription of antibiotics and this knowledge
could be useful when developing guide-
lines or educational material for GPs. 
Methods
The study population was all GPs (576) in
the Avon Health Authority, a population
of approximately one million, including
Bristol and Bath. The survey was a five
page questionnaire with 14 questions and
83 items concerning the diagnosis and
treatment of acute bronchitis, and includ-
ing GP demographic data. 
We tested categorical variables using
the chi-squared test and continuous vari-
ables using the unpaired t test to
investigate if there were differences
between responders and nonresponders.
To assess thresholds for treatment using
signs and symptoms GPs were asked to
rate a list of eight terms in order of
importance for deciding if a person (who
was otherwise healthy) required antibi-
otics for ARI. They were allowed to give
different signs and symptoms the same
rating. To determine the rankings, each
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rating was assigned a value that took into
account how many symptoms or signs
were rated by each GP and whether
different signs and symptoms were given
the same rating (using the proc rank pro-
cedure in SAS). For the remaining
questions we measured and compared
proportions. We also analysed the data by
the GPs’ age and whether they belonged
to a teaching practice.
Results
Four hundred and nineteen GPs returned
the questionnaire. Their demographic and
practice characteristics were compared with
nonresponders (Table 1). Nonresponders
were less likely to have the MRCGP
(p<0.01), belong to a teaching (p=0.001)
or training practice (p<0.01) and were
more likely to be older (p<0.001). In a
regression model using these characteris-
tics, independent associations for
nonresponse were: not being part of a
teaching practice OR=2.01 (1.38–3.13);
and increasing age OR=1.04 (1.01–1.07).
General practitioners were asked to
rate a list of symptoms in order of impor-
tance for deciding if a patient required
antibiotics for a ARI (Table 2). Many
(89%) said sputum colour affected their
decision to treat.
We asked how often GPs felt that
patient pressure influenced their decision
to prescribe antibiotics in consultations
for respiratory infection: 6% thought it
occurred for 1 in 3; 33% for 1 in 5; and
48% for 1 in 10. Less than 2% thought
they were never influenced by patient
expectation. To determine why they pre-
scribed, GPs were given a choice of
several possible reasons from which to
choose (Table 3). About half (204, 49%)
answered all the questions: no response
was given by seven (2%). Most responded
yes to one or both of the reasons centred
on patient satisfaction with only 36 saying
no to both reasons; and 50 not respond-
ing. Of these 86 GPs, 60 (70%) sometimes
prescribed to stop reattendance either to
Table 1. Demographic and practice characteristics of responders
and nonresponders to a postal questionnaire about the diagnosis
and treatment of acute bronchitis
GP characteristic Responders Nonresponders 
n=419 n=157
Age (average) 44.1 years 46.8 years
Male 252 (60%) 104 (66%)
Years in general practice 13.6 11.4
Full time 361 (86%) 134 (86%) 
Practice size (number of partners) 4.9 4.5
Is a senior partner 92 (22%) 42 (27%)
Belongs to a teaching practice 182 (43%) 67 (43%)
Belongs to a training practice 140 (33%) 38 (24%)
Has MRCGP 268 (64%) 80 (51%)
Table 2. The importance of symptoms and signs for deciding if a
person (who is otherwise healthy) requires antibiotics for a
respiratory tract infection 
Sign or symptom* Ranking
Crepitations or crackles (but no sign of consolidation) on examination 1st
Presence of fever equal 2nd
Sputum type (eg. purulent/non/purulent) equal 2nd 
Rhonchi on examination 4th
Feeling unwell/time off work equal 5th
Character of cough equal 5th
Smoking status of patient 7th
Duration of cough 8th
* other was another choice but few GPs used this option
Table 3. Reasons for prescribing an antibiotic if patient pressure
was thought to influence the decision to prescribe
Reason Yes No
(n% of all GPs) (n% of all GPs)
Keep the patient happy 192 (46%) 88 (21%)
Maintain a good relationship with them 268 (64%) 60 (14%)
Stop them returning to see another GP 159 (38%) 114 (27%)
Prevent them from attending again 164 (39%) 123 (29%)
Because their usual GP prescribes them 145 (35%) 128 (31%)
To end the consultation 133 (32%) 135 (32%)
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themselves or another doctor, eight (9%)
because the patients’ usual GP did so or
to end the consultation and the remaining
18 responded with comments such as:
• ‘because I can’t get across that antibi-
otics won’t work despite careful
explanation’ 
• ‘in case I am wrong’
• ‘prevent out of hours visits’ and
• ‘if it is a Friday of a bank holiday
weekend’.
When asked what other treatments they
might advise for the treatment of acute
bronchitis 47% would use bronchodilators,
38% over-the-counter medications (eg.
cough mixtures), 23% would give a pre-
scription for a cough suppressant or
expectorant and 96% would advise the
symptomatic use of paracetamol and fluids.
General practitioners were asked to
rank their choices of antibiotics (for
smokers and nonsmokers) 1–7 in order of
preference (Table 4). 
There were no differences by logistic
regression analysis in these results
between GPs by age or being in a teach-
ing practice.
Discussion
While surveys of how GPs treat acute
bronchitis have recently been reported
from America9 and from Europe10 no
equivalent survey has been undertaken in
the UK or Australia. Furthermore these
studies explored treatment choices not
thresholds or reasons for treatment. 
General practitioners place most
importance on three specific clinical
symptoms and signs: purulent sputum,
fever and crepitations/crackles on chest
examination when deciding when to treat
ARI with antibiotics. This is consistent
with the recorded behaviour of GPs in a
study of acute lower respiratory tract
infections (LRTI).11 However, although
an association between the presence of
focal chest signs and radiographic pneu-
monia has been reported12 the prognostic
significance of sputum and chest signs has
been questioned.13,14 Fever may be an
important sign, but probably only in asso-
ciation with other factors such as age,
respiratory rate, pulse and comorbidity.15
That most GPs report that sputum
colour influences their decision to pre-
scribe antibiotics is consistent with past
research.16 However, there is no evidence
that the appearance of sputum is related
to bacterial colonisation or the efficacy of
antibiotics.17 By contrast signs that may
indicate a need for antibiotics (frequent
cough and feeling ill),18 were not highly
rated by most GPs.
Patient factors are clearly important in
the decision to prescribe antibiotics.
Similar data were obtained from a study
of LRTI in which GPs were uncertain of
the value of their own antibiotic prescrip-
tion in 36% of patients.11 The influence of
patient expectations has been shown to
affect the prescribing behaviour of GPs
for both upper19 and lower8 ARI. These
expectations may be driven by the patient
view that they have an ‘infection’ and
therefore require antibiotics.8 When
added to the evidence that patient expec-
tations also affect reconsultation rates,20,21
it is clear how a self sustaining cycle of
illness behaviour can be established if
antibiotics are prescribed.
Many GPs believe prescribing an
antibiotic assists maintenance of a good
relationship with their patient. However,
patient satisfaction is not always
increased when an antibiotic is pre-
scribed,22 depends more on doctor–patient
communication than on antibiotic treat-
ment and it may be that the GPs opinion
about patient expectation is the strongest
determinant for prescribing.23,24
When GPs do prescribe an antibiotic
it is usually amoxycillin. This is consistent
with data from Australia,3 UK11 and US.9
But German GPs favour tetracycline,
Italian cephalosporins and Spanish
macrolides.10 These differences could be
due to differences in training, local adver-
tising or patient preferences. 
What are the alternatives to antibi-
otics? Most GPs suggest fluids and
paracetamol and many also use bron-
chodilators, although their use has
recently been questioned. Ruling out a
serious cause for symptoms may be all
that patients want.25 Furthermore simple
strategies such as delayed prescribing and
patient information leaflets decrease
antibiotic use and reconsultation.20,26 But if
it is unclear what the benefits of treat-
ment are, patients may be justified in
having unrealistic expectations and GPs
forgiven for over prescribing antibiotics. 
There are several limitations of the
study. Postal questionnaires may be
subject to bias. But there was a high
response rate and, moreover, although
comparison of responders with nonre-
sponders indicated that older GPs and
those not in a teaching practice were less
Table 4. Choice of antibiotic for a patient with acute bronchitis who
has no significant past medical history and no known allergies 
Number (%) of GPs choosing this rank
Antibiotic For a nonsmoking patient For a smoking patient
Amoxycillin 1st 405 (96.7%) 1st 354 (84.5%)
Erythromycin 2nd 271 (64.7%) 2nd 221 (52.7%)
Co-amoxiclav 3rd 134 (32.0%) 3rd 115 (27.4%)
Cephlosporin 4th 81 (19.6%) equal 4th 83 (19.8%)
Clarithromycin 5th 87(20.8%) equal 4th 83 (19.8%)
Doxycycline 6th 78 (18.6%) 6th 69 (16.5%)
Trimethoprim 7th 137(32.7%) 7th 123 (29.4%)
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likely to return the questionnaire, analysis
examining differences in response
between groups (in those who returned
the questionnaire) indicated no signifi-
cant differences. Additionally while
reported and actual behaviour may differ
and socially desirable answers given —
especially in face-to-face interviews — the
questionnaire was confidential and our
results consistent with the literature.
This study shows that there are differ-
ences between GP behaviour and existing
evidence. There is a need to clarify who
should receive what treatment. This can
only be achieved by large, well designed,
randomised controlled trials of treatment
in patient groups that are defined by clini-
cal signs and symptoms and not
diagnostic labels that are subject to
between practitioner variation.27
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Implications of this study
for general practice
• The use of antibiotics for acute
bronchitis is determined by the
presence of purulent sputum,
fever or chest signs that are only
partly evidence based.
• Psychosocial patient factors
heavily influence prescribing for
acute bronchitis.
• Amoxycillin is the antibiotic of
choice for acute bronchitis.
• Most GPs suggest other
symptomatic treatments, including
paracetamol and fluids.
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